Gene Therapy Global Market Report 2023

Feb 2023| TBR1136E| TBRC (Publisher)

Report Highlights

Including: 1) By Gene Type: Antigen; Cytokine; Suicide Gene
2) By Vector: Viral Vector; Non-Viral Vector
3) By Application: Oncological Disorders; Rare Diseases; Cardiovascular Diseases; Neurological Disorders; Infectious Diseases
4) By End Users: Hospitals; Homecare; Specialty Clinics
Covering: Novartis AG; Bluebird Bio, Inc.; Spark Therapeutics, Inc.; Audentes Therapeutics; Voyager Therapeutics

Gene Therapy Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gene therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Description:
Where is the largest and fastest growing market for gene therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gene therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2022-2032
Units considered $ Billion
Segments covered By Gene Type, By Vector, By Application, By End Users
Industry covered Pharmaceuticals
Regions covered Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Countries covered Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA
Companies studied
  • Spark Therapeutics, Inc.
  • Celgene Corporation
  • Audentes Therapeutics
  • Voyager Therapeutics
  • Applied Genetic Technologies Corporation
  • Novartis AG
  • UniQure N.V.
  • Bluebird Bio, Inc.
  • Sarepta Therapeutics, Inc.
  • Cellectis S.A.
  • Sangamo Therapeutics
  • Gilead Lifesciences, Inc.
  • Orchard Therapeutics
  • Sibiono GeneTech Co., Ltd.
  • Gensight Biologics S.A.
  • Shanghai Sunway Biotech Co., Ltd.
  • Biogen
  • Bristol-Myers Suibb Company
  • Sangamo Therapeutics
  • Audentes Therapeutics
  • Regenxbio, Inc.
  • Gegenxbio, Inc
  • Oxford BioMedica plc.
  • Dimension Therapeutics, Inc.
  • Taxus Cardium Pharmaceuticals Group, Inc. (Gene Biotherapeutics)
  • Sanofi
  • Calimmune, Inc.
  • Shrine Plc
  • Benitech Biopharma
  • Transgene
  • Epeius Biotechnologies Corp.

Scope

Markets Covered:

  • By Gene Type: Antigen; Cytokine; Suicide Gene; Other Gene types
  • By Vector: Viral Vector; Non-Viral Vector; Other Vectors
  • By Application: Oncological Disorders; Rare Diseases; Cardiovascular Diseases; Neurological Disorders; Infectious Diseases; Other Applications
  • By End Users: Hospitals; Homecare; Specialty Clinics; Other End-Users

Companies Mentioned: Novartis AG; Bluebird Bio, Inc.; Spark Therapeutics, Inc.; Audentes Therapeutics; Voyager Therapeutics

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

  • Table 1 : Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2 : Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3 : Global Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4 : Global Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5 : Global Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6 : Global Gene Therapy Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7 : Global Gene Therapy Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8 : Global Gene Therapy Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9 : Asia-Pacific, Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10 : Asia-Pacific, Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11 : China, Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12 : China, Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13 : India, Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14 : India, Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15 : Japan, Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16 : Japan, Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17 : Australia, Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18 : Australia, Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19 : Indonesia, Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20 : Indonesia, Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21 : South Korea, Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22 : South Korea, Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23 : Western Europe, Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24 : Western Europe, Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25 : UK, Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26 : UK, Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27 : Germany, Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28 : Germany, Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29 : France, Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30 : France, Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31 : Eastern Europe, Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32 : Eastern Europe, Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33 : Russia, Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34 : Russia, Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35 : North America, Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36 : North America, Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37 : USA, Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38 : USA, Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39 : South America, Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40 : South America, Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41 : Brazil, Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42 : Brazil, Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43 : Middle East, Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44 : Middle East, Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45 : Africa, Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 46 : Africa, Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 47 : Novartis AG Financial Performance
  • Table 48 : Bluebird Bio, Inc. Financial Performance
  • Table 49 : Spark Therapeutics, Inc. Financial Performance
  • Table 50 : Audentes Therapeutics Financial Performance
  • Table 51 : Voyager Therapeutics Financial Performance
  • Figure 1 : Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2 : Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3 : Global Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4 : Global Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5 : Global Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6 : Global Gene Therapy Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7 : Global Gene Therapy Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8 : Global Gene Therapy Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9 : Asia-Pacific, Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10 : Asia-Pacific, Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11 : China, Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12 : China, Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13 : India, Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14 : India, Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15 : Japan, Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16 : Japan, Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17 : Australia, Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18 : Australia, Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19 : Indonesia, Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20 : Indonesia, Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21 : South Korea, Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22 : South Korea, Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23 : Western Europe, Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24 : Western Europe, Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25 : UK, Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26 : UK, Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27 : Germany, Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28 : Germany, Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29 : France, Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30 : France, Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31 : Eastern Europe, Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32 : Eastern Europe, Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33 : Russia, Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34 : Russia, Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35 : North America, Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36 : North America, Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37 : USA, Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38 : USA, Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39 : South America, Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40 : South America, Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41 : Brazil, Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42 : Brazil, Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43 : Middle East, Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44 : Middle East, Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45 : Africa, Gene Therapy Market, Segmentation By Gene Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 46 : Africa, Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 47 : Novartis AG Financial Performance
  • Figure 48 : Bluebird Bio, Inc. Financial Performance
  • Figure 49 : Spark Therapeutics, Inc. Financial Performance
  • Figure 50 : Audentes Therapeutics Financial Performance
  • Figure 51 : Voyager Therapeutics Financial Performance

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Similar Reports from TBRC (Publisher)

Gene Therapy Global Market Report 2022

  • Date - Mar 2022
  • Code - TBR1136D

Including: 1) By Vector: Viral Vector; Non-Viral Vector; Others
2) By Application: Oncological Disorders; Rare Diseases; Cardiovascular Diseases; Neurological Disorders; Infectious Diseases; Others
3) By End Users: Hospitals; Homecare; Specialty Clinics; Others
Covering: Novartis AG; Bluebird Bio, Inc.; Spark Therapeutics, Inc.; Audentes Therapeutics; Voyager Therapeutics; Applied Genetic Technologies Corporation

Gene Therapy Global Market Report 2022 from The ...

Gene Therapy Global Market Report 2022

  • Date - Mar 2022
  • Code - TBR1136C

Including: 1) By Gene Type: Antigen; Cytokine; Suicide Gene; Others
2) By Vector: Viral Vector; Non-Viral Vector; Others
3) By Application: Oncological Disorders; Rare Diseases; Cardiovascular Diseases; Neurological Disorders; Infectious Diseases; Others
4) By End Users: Hospitals; Homecare; Specialty Clinics; Others
Covering: Novartis AG; Bluebird Bio, inc.; Spark Therapeutics, inc.; Audentes Therapeutics; Voyager Therapeutics; Applied Genetic ...

Gene Therapy Global Market Report 2021: COVID 19 Growth And Change to 2030

  • Date - Jun 2021
  • Code - TBR1136B

Including: 1) By Gene Type: Antigen; Cytokine; Suicide Gene; Others
2) By Vector: Viral Vector; Non-Viral Vector; Others
3) By Application: Oncological Disorders; Rare Diseases; Cardiovascular Diseases; Neurological Disorders; Infectious Diseases; Others
4) By End Users: Hospitals; Homecare; Specialty Clinics; Others

Covering: Novartis AG; Bluebird bio, Inc.; Spark Therapeutics, Inc.; Audentes Therapeutics; Voyager Therapeutics

Gene Therapy Global Market Report 2021: ...

Gene Therapy Global Market Report 2020-30: Covid 19 Growth and Change

  • Date - Nov 2020
  • Code - TBR1136A

Including: 1) By Gene Type: Antigen; Cytokine; Suicide Gene; Others
2) By Vector: Viral Vector; Non-Viral Vector; Others
3) By Application: Oncological Disorders; Rare Diseases; Cardiovascular Diseases; Neurological Disorders; Infectious Diseases; Others
4) By End Users: Hospitals; Homecare; Specialty Clinics; Others

Covering: Novartis AG; Bluebird bio, Inc.; Spark Therapeutics, Inc.; Audentes Therapeutics; Voyager Therapeutics

Gene Therapy Global Market Report ...

The Business Research Company
Price: $5000

Become a Member

Already a member? Login here.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS